Keywords: fda, tee, review, tysabri, crohn, ireland-based, elan

FDA C'tee to review Tysabri for Crohn's

Article | 04 June 2007

Print This

Ireland-based Elan Corp and US firm Biogen Idec say that the Gastrointestinal Drugs Advisory Committee and Drug Safety and Risk ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in